Our current study for the first time revealed that Apigenin pretreatment could inhibit proliferation of NPC cells induced by C5a; however Apigenin treatment at the same time with C5a treatment had no significant effect. The gene discussed is C5; the disease is nasopharyngeal carcinoma.